Product image of Linezolid Krka (Linezolid) supplied by GNH India

Linezolid Krka

Active Ingredient:
Linezolid
Origin:
EU

Linezolid Krka (Linezolid)

Linezolid, the active ingredient in Linezolid Krka, is an oxazolidinone antibiotic presented as an oral dosage form for systemic use. It is employed to treat infections caused by Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA) and vancomycin‑resistant Enterococcus (VRE), in adult patients. It is also indicated for community‑acquired and hospital‑acquired pneumonia and for skin and soft‑tissue infections.

GNH India supplies Linezolid Krka as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation to support global distribution.

Manufacturer / TM Owner

Krka, D.D., Novo Mesto

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Linezolid is an oxazolidinone antibiotic used to treat infections caused by Gram‑positive bacteria.

  • Methicillin‑resistant Staphylococcus aureus (MRSA) infections: eradicates the pathogen and resolves the infection.
  • Vancomycin‑resistant Enterococcus (VRE) infections: eliminates resistant strains and restores clinical improvement.
  • Community‑acquired and hospital‑acquired pneumonia: clears pulmonary infection and improves respiratory function.
  • Skin and soft‑tissue infections: reduces bacterial load and promotes wound healing.

How It Works

  • Linezolid binds to the 50S subunit of bacterial ribosomes, preventing formation of the initiation complex required for protein synthesis. By inhibiting the early stage of translation, it stops bacterial growth and leads to bacteriostatic activity against susceptible Gram‑positive organisms.

Side Effects

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects

  • Nausea: mild to moderate stomach upset.
  • Diarrhea: loose stools that may be watery.
  • Headache: transient cranial discomfort.
  • Vomiting: occasional emesis.
  • Metallic taste: persistent metallic sensation in the mouth.
  • Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects

  • Thrombocytopenia: significant drop in platelet count.
  • Peripheral neuropathy: tingling or numbness in extremities.
  • Serotonin syndrome: risk when combined with serotonergic agents.
  • Myelosuppression: bone‑marrow suppression affecting blood cells.
  • Lactic acidosis: accumulation of lactate causing metabolic disturbance.
  • Optic neuropathy: visual disturbances due to optic nerve involvement.

Precautions & Warnings

Before prescribing Linezolid, consider patient‑specific factors and monitor appropriately.

  • Renal impairment: adjust therapy and monitor renal function.
  • Hepatic impairment: use with caution and assess liver enzymes.
  • Concomitant serotonergic drugs: avoid due to risk of serotonin syndrome.
  • Hematologic monitoring: regularly check complete blood counts for cytopenias.
  • Hypersensitivity: discontinue if allergic reaction occurs.
  • Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Avoid Interactions

Linezolid can interact with several drug classes, requiring vigilance.

Major Interactions (Avoid)

  • Monoamine oxidase inhibitors (MAOIs): may precipitate hypertensive crisis.
  • Selective serotonin reuptake inhibitors (SSRIs) and SNRIs: increase risk of serotonin syndrome.
  • Tyramine‑rich foods: can cause severe hypertension when combined.

Moderate Interactions (Monitor Closely)

  • Rifampin: reduces linezolid plasma concentrations.
  • Antacids containing aluminum or magnesium: may decrease absorption.
  • Warfarin: potential alteration of INR, requiring coagulation monitoring.

Frequently Asked Questions

Linezolid Krka is indicated for infections caused by Gram‑positive bacteria, including methicillin‑resistant Staphylococcus aureus (MRSA), vancomycin‑resistant Enterococcus (VRE), community‑acquired and hospital‑acquired pneumonia, as well as skin and soft‑tissue infections.

Linezolid inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit, preventing formation of the initiation complex required for translation. This action halts bacterial growth and leads to a bacteriostatic effect against susceptible Gram‑positive organisms.

The dosage of Linezolid Krka is determined by the prescribing clinician based on the specific infection, patient weight, renal and hepatic function, and local treatment guidelines. Patients should follow the prescriber’s instructions precisely.

The safety of linezolid in pregnancy and lactation has not been definitively established. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Linezolid Krka, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Linezolid belongs to the oxazolidinone class and offers oral bioavailability, making it convenient for outpatient therapy. Compared with vancomycin, it does not require intravenous administration and has a different resistance profile, but both are effective against MRSA. Choice depends on infection severity, patient factors and susceptibility patterns.

Store Linezolid Krka at ambient temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Linezolid Krka is administered orally, typically as tablets or oral suspension, and should be taken with or without food as directed by the prescriber. The full course should be completed even if symptoms improve to prevent resistance.

Serious risks include thrombocytopenia, peripheral neuropathy, serotonin syndrome when combined with serotonergic agents, myelosuppression, lactic acidosis, and optic neuropathy. Patients should be monitored regularly for hematologic changes and neurological symptoms.

Linezolid Krka should be avoided in patients with known hypersensitivity to linezolid or other oxazolidinones, in those taking monoamine oxidase inhibitors, and in individuals with uncontrolled hypertension who consume tyramine‑rich foods without medical supervision.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Linezolid

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT